Drug intelligence / Profile preview

12R-HEPE

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

12R-HEPE is a hydroxy derivative of eicosapentaenoic acid (EPA) with the molecular formula C20H30O3. It is classified as a HEPE (hydroxyeicosapentaenoic acid) and has been reported to occur naturally in the red alga Murrayella periclados. The compound features a hydroxyl group at the 12-carbon position with R stereochemistry and contains five double bonds in a specific configuration (5Z,8Z,10E,14Z,17Z). 12R-HEPE is found as an ingredient in some omega-3 formulations like Luvira, where it is combined with other omega-3 fatty acids for dietary supplementation.

Other names: (12R)-12-hydroxyeicosapentaenoic acid12(R)-HEPE12-Hydroxyeicosapentaenoic acid, (12R)-12R-hydroxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid(5Z,8Z,10E,12R,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid5,8,10,14,17-Eicosapentaenoic acid, 12-hydroxy-, (5Z,8Z,10E,12R,14Z,17Z)-

Beyond the preview

Go deeper on 12R-HEPE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 12R-HEPE.

Explore the full profile